LOGIN  |  REGISTER
Recursion
Terns Pharmaceuticals

Ardent Health to Participate in Upcoming Investor Conferences

November 05, 2024 | Last Trade: US$ 16.27 0.00 0.00

BRENTWOOD, Tenn. / Nov 05, 2024 / Business Wire / Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing midsize urban communities across the U.S., today announced that members of the Company’s management team will participate in the following upcoming investor conferences:

  • Stephens Annual Investment Conference on Tuesday, November 19, in Nashville, Tennessee. Members of the management team will participate in a fireside chat discussion at 10:00 a.m. ET that same day.
  • Citi 2024 Global Healthcare Conference on Tuesday, December 3, in Miami, Florida.
  • Bank of America Securities Leveraged Finance Conference on Wednesday, December 4, in Boca Raton, Florida.

A live audio webcast of the fireside chat discussions will be available at the Investor Relations section of the Company’s website, at https://ir.ardenthealth.com, and a replay will be available for 90 days using the same link.

In conjunction with these conferences, the Ardent Health management team will be available to participate in one-on-one meetings with investors registered to attend each conference. For more information, please contact your sales representative at the host firm, or Dave Styblo, Ardent Health’s senior vice president of investor relations at This email address is being protected from spambots. You need JavaScript enabled to view it..

About Ardent Health

Ardent Health (NYSE: ARDT) is a leading provider of healthcare in growing mid-sized urban communities across the U.S. With a focus on people and investments in innovative services and technologies, Ardent is passionate about making healthcare better and easier to access. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and more than 200 sites of care with over 1,700 affiliated providers across six states. For more information, please visit www.ardenthealth.com.

Stock Quote

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB